Assessment of 2-Year Mortality With Use of Drug-Coated Devices in Femoropopliteal Disease: A Real World Experience from The Bronx, New York

Abstract

We sought to compare the 2-year mortality outcome in patients with femoropopliteal arterial disease treated with drug-coated devices (DCDs) vs those treated with non-drug-coated devices (nDCDs) in an inner-city public hospital that mainly serves patients of lower socioeconomic status.